This startup develops AI-assisted custom cell culture media specifically for cellular therapies and tissue engineering. Their technology aims to optimize media formulations to improve the growth and function of cells used in advanced therapeutic applications.
Funding
Funding not disclosed
Founders
Product
Problem
Cellular therapies and tissue engineering rely on cell culture media, but traditional media formulations often fail to adequately support the specific growth and functional requirements of cells used in these advanced therapeutic applications. This can lead to suboptimal cell performance and inconsistent therapeutic outcomes.
Solution
MetabolIQ develops AI-assisted custom cell culture media tailored for cellular therapies and tissue engineering. Their technology optimizes media formulations to enhance cell growth and function, leading to improved outcomes in advanced therapeutic applications. By leveraging artificial intelligence, MetabolIQ creates media that meet the unique metabolic demands of specific cell types, ensuring optimal cell health and performance. This approach aims to improve the efficacy and reproducibility of cell-based therapies.
Target Audience
The primary customers are researchers and companies involved in cellular therapies, tissue engineering, and regenerative medicine.
Features
- AI-driven media formulation optimization
- Custom media designed for specific cell types used in cellular therapies and tissue engineering
- Enhanced cell growth and function compared to traditional media